Daniel P. Finke - Apr 1, 2023 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP/Pres, Health Care Benefits
Signature
/s/ Daniel P. Finke
Stock symbol
CVS
Transactions as of
Apr 1, 2023
Transactions value $
$5,229,343
Form type
4
Date filed
4/4/2023, 04:27 PM
Previous filing
Aug 5, 2022
SEC
View on sec.gov

Transactions Table

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CVS Stock Option Award $5.52M +74.2K $74.31 74.2K Apr 1, 2023 Common Stock 74.2K $74.31 Direct F7
holding CVS Stock Option 16.2K Apr 1, 2023 Common Stock 16.2K $54.19 Direct F2
holding CVS Stock Option 27.2K Apr 1, 2023 Common Stock 27.2K $58.34 Direct F3
holding CVS Stock Option 82.1K Apr 1, 2023 Common Stock 82.1K $74.30 Direct F4
holding CVS Stock Option 19.1K Apr 1, 2023 Common Stock 19.1K $52.37 Direct F5
holding CVS Stock Option 52K Apr 1, 2023 Common Stock 52K $101.09 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.
F2 Option became exercisable in four equal annual installments, beginning on 4/1/2020.
F3 Option became exercisable in four equal annual installments, commencing 4/1/2021.
F4 Option became exercisable in four equal annual installments, commencing 4/1/2022.
F5 Option became exercisable in three equal annual installments, commencing 5/31/2022.
F6 Option became exercisable in four equal annual installments, commencing 4/1/2023.
F7 Option becomes exercisable in four equal annual installments, commencing 4/1/2024.